Pipeline
Innovative new drug platform technology and research
Development of new drugs using biomaterials such as peptides, antibody proteins, and genes
BHD1028 platform technology
Cure target and subject
- Design of substances targeting the hormone adiponectin and associated receptor
- Various diseases arising from adiponectin hormone deficiency
Drugs
- Peptide consisting of 15 amino acids with high affinity for the receptor
- High efficacy and stability
- Various formulations
Treatment effects
- Targeting fundamental disease treatments Quality of life and life extension Expansion of treatment opportunities
What is BHD1028?
-
-
01
High affinity peptide agonist
to Adiponectin Receptors (Adipo R1 & Adipo R2)- High affinity for the receptor
- Outstanding efficacy
- Effective design
-
-
02
Coupled modeling of BHD1028 and adipoR
- Design based on structural and chemical modeling that maximizes biological activation
-
-
03
Advantages of Peptide Drug
- Excellent peptide medicine
- Stable
- Relatively low production cost
